Pharmacokinetic actions of exendin‐4 in the rat: Comparison with glucagon‐like peptide‐1

This publication has 20 references indexed in Scilit:

• Potential Therapeutic Levels of Glucagon-Like Peptide I Achieved in Humans by a Buccal Tablet
  Diabetes Care, 1996
• Glucagon-like peptide-1(7–37) has a larger volume of distribution than glucagon-like peptide-1(7–36)amide in dogs and is degraded more quickly in vitro by dog plasma
  European Journal of Drug Metabolism and Pharmacokinetics, 1996
• Preliminary report Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7–36)NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake
  Metabolism, 1996
• Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo
  Journal of Clinical Endocrinology & Metabolism, 1995
• Stable expression of the rat GLP-I receptor in CHO cells: Activation and binding characteristics utilizing GLP-I(7–36)-amide, oxyntomodulin, exendin-4, and exendin(9–39)
  Peptides, 1994
• Exendin-4 and exendin-(9–39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7–36)NH2
  European Journal of Pharmacology: Molecular Pharmacology, 1994
• Rat gastric somatostatin and gastrin release: Interactions of exendin-4 and truncated glucagon-like peptide-1 (GLP-1) amide
  Life Sciences, 1994
• Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum
  European Journal of Biochemistry, 1993
• Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
  Digestive Diseases and Sciences, 1993
• Uranyl nitrate-induced acute renal failure in the rat: Micropuncture and renal hemodynamic studies
  Kidney International, 1974